成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >MOTS-c (human)
MOTS-c (human)
  • MOTS-c (human)
  • MOTS-c (human)
  • MOTS-c (human)
  • MOTS-c (human)
  • MOTS-c (human)

MOTS-c (human) NEW

Price $26
Package 1box
Min. Order: 1box
Supply Ability: 10000box
Update Time: 2024-05-15

Product Details

Product Name: MOTS-c (human) CAS No.: 121283-65-6
Min. Order: 1box Purity: 99%
Supply Ability: 10000box Release date: 2024/05/15

Chinese Name :MOTS-c (human)

English name :MOTS-c (human)

CAS number :121283-65-6

CBNumber:CB53551542

Molecular formula :C52H74F3N15O13

Molecular weight :1174.25

Appearance: White or white crystalline powder

use

Synthesis of pharmaceutical intermediates


Company Profile Introduction

Shanghai Getian Industrial Co.,Ltd is a leading enterprise committed to providing quality products and efficient logistics services. We are proud to introduce a range of products with excellent quality, and the industrial materials are subject to strict quality control to ensure that the high standards of our customers are met. We have pharmaceutical raw material production factory and reagent research and development center. We now have a complete product line. In addition, we have developed and produced tens of thousands of reagents. We are complemented by a custom synthesis business of various organic compounds. We can synthesize almost any chemical.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$30.00/1box
VIP1Y
hebei hongtan Biotechnology Co., Ltd
2024-03-21
$420.00/1g
VIP3Y
Hebei Dangtong Import and export Co LTD
2024-09-13
$0.00/1kg
VIP1Y
Shanghai Affida new material science and technology center
2024-05-06
$30.00/1Box
VIP1Y
zhuzhou dingcheng meihei comestic co.,ltd
2023-12-05
$10.00/10vial
VIP2Y
Wuhan Cell Pharmaceutical Co., Ltd
2023-03-31
  • Since: 2024-01-19
  • Address: Hong Kong
INQUIRY